Skip to content
Q1 '26Q4 '25Q3 '25Q1 '25Q4 '24
$11.22M+121%$5.08M+63.4%$3.11M+97.5%$1.57M+80.2%$872.6K+10.6%
$11.45M+120%$5.2M+57.7%$3.29M$1.1M
$919.95K-0.2%$922.17K+1.9%$904.89K$821.93K
$18.64M+53.3%$12.16M+183%$4.3M$2.05M
$5.13M-14.5%$6M+160%$2.31M$707.93K
$5.94M
$12.53M+67.6%$7.48M+97.1%$3.79M$2.23M
$500M0.0%$500M0.0%$500M$2.68K
-$23.36M-4.3%-$22.39M+1.2%-$22.67M-$19.2M
$6.12M+30.5%$4.69M+830%$504.02K-38.4%$818.71K+561%-$177.43K+57.2%
$18.64M+53.3%$12.16M+183%$4.3M$2.05M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Turn Therapeutics Inc. Common Stock's total assets?
Turn Therapeutics Inc. Common Stock (TTRX) holds $18.6M in total assets.
How much debt does Turn Therapeutics Inc. Common Stock have?
Turn Therapeutics Inc. Common Stock carries $6.0M in total debt against $6.1M of shareholders' equity, a debt-to-equity ratio of 0.98.
How much cash does Turn Therapeutics Inc. Common Stock have?
Turn Therapeutics Inc. Common Stock holds $11.2M in cash and equivalents.
Can Turn Therapeutics Inc. Common Stock cover its short-term obligations?
Its current ratio is 2.23 — current assets exceed current liabilities.
Where does Turn Therapeutics Inc. Common Stock's balance sheet data come from?
Every line is extracted from Turn Therapeutics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.